|
|
|
Clinical TrialsBone Metastasis:CZOL446E2352: A Phase III 3-arm study of continued efficacy and safety of Zometa for patients with breast cancer and bone metastases. [VCHOS]
For more information on VCHOS trials, please call Ruth Ann Begun, OCN at (805) 485-8709 ext 136 or email at rbegun@venturaoncology.comFor more information on UCLA network trials, please call Sharon Feinberg, RN at (805) 485-8709 ext 129 or email at sfeinberg@mednet.ucla.edu. |
|